RECENT NEWS

The Department of Health and Social Care (DHSC), with the support of the NHS, has launched a major new national campaign to increase the number of those eligible attending their cervical screening in England.

Patients will receive better, more joined-up care under new plans announced to improve the links between health and social care.

Medovate has announced that it has entered into an agreement with Mercury Medical for exclusive distribution of the FDA-cleared device SAFIRA (SAFer Injection for Regional Anesthesia) across the whole of the US.

Biases in artificial intelligence will aim to be eradicated in a world first as the NHS in England trials a new approach to the ethical adoption of AI in healthcare.

Patients waiting for major procedures will be given extensive support from dedicated NHS care teams to make sure they are fighting fit for surgery.

Thousands of patients are set to benefit from pioneering new technology being backed by the NHS that aims to revolutionise cancer testing techniques across the country.

An innovative new drug for treating advanced or recurrent endometrial cancer in adults who have had platinum-based chemotherapy is being recommended by NICE as an option for use within the Cancer Drugs Fund.

HCA Healthcare UK has opened the doors to its latest investment in complex cancer care; a £26milion specialist complex haematology and oncology unit at HCA Healthcare UK at University College Hospital.

Patients waiting for elective surgeries will benefit from increased transparency and information sharing following the launch of the new NHS ‘My Planned Care’ platform.

Health and Social Care Secretary Sajid Javid has declared "a war on cancer” and launched a call for evidence to underpin an ambitious 10-Year Cancer Plan for England.

Researchers have found that the introduction of a bundle of evidence-based practices reduced death or severe brain bleeding from 27.4% to 15% in premature babies.

Switching from a metered dose inhaler to a dry powder version for maintenance therapy more than halves the carbon footprint of people with asthma, and without any worsening of their condition, finds a study published online in the journal Thorax.

The NHS has struck a deal for a life-saving treatment, reportedly the most expensive drug in the world, that will offer babies and young children with a rare genetic disease the prospect of a normal life.

The Government is launching a consultation to protect NHS funding by tackling increasing and disproportionate legal fees for lower value clinical negligence claims.

Rutherford Health, a leading independent provider of advanced cancer care in the UK, has announced it has offered its treatment and diagnostic services to the National Health Service on a not-for-profit basis for the next three years.

The UK Government welcomed a panel of esteemed UK and UAE experts in its digital health at Arab Health 2022, to explore the role digital health has in improving patient outcomes in the UK and the Middle East.

Jeddah, in the Kingdom of Saudi Arabia, is set to become home to a 150 bed world-class multi-specialty hospital, which will be fully integrated with King’s College Hospital’s facilities in London.

CMR Surgical (CMR) has announced the Versius Surgical Robotic System has been indicated for thoracics to support surgeons providing minimally invasive surgery to patients undergoing operations in the lungs, thymus and oesophagus.

Researchers at the Case Western Reserve University School of Medicine have found that people who received the Moderna vaccine were less likely to experience “breakthrough” COVID-19 cases, compared to recipients of the Pfizer vaccine.

Record numbers of people are coming forward for cancer tests, with almost a quarter of a million referrals in one month according to the latest data from NHS England.